Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.44 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 6/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2941633 | 0.74 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPCPB2ANPEP | |
| SCHEMBL456395 | 0.74 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPCPB2ANPEP | |
| SCHEMBL28547750 | 0.74 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPCPB2ANPEP | |
| SCHEMBL2941639 | 0.74 | PTGS1 (0.55) | PTGS1SLC7A11ENPEPCPB2ANPEP | |
| SCHEMBL3165379 | 0.72 | PTGS1 (0.43) | PTGS1SLC7A11ENPEPALDH1A1MAPT | |
| SCHEMBL28440494 | 0.72 | — | — | |
| SCHEMBL31130601 | 0.72 | — | — | |
| SCHEMBL2941641 | 0.72 | — | — | |
| SCHEMBL359013 | 0.72 | — | — | |
| SCHEMBL27589324 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117003822-A | SG3C bromobenzyl ether derivative, preparation method and application | 江苏省原子医学研究所 | 2023-11-07 | — | — | CN | claimed |
| CN-117003815-A | SG2C bromobenzyl ether derivative, preparation method and application | 江苏省原子医学研究所 | 2023-11-07 | — | — | CN | claimed |
| EP-1679318-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2006-07-12 | — | — | EP | claimed |
| EP-1337549-B1 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE SA (CH) | 2006-04-05 | — | — | EP | claimed |
| US-20050239162-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2005-10-27 | — | — | US | claimed |
| EP-1337549-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2003-08-27 | — | — | EP | claimed |
| WO-2002050099-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | WO | claimed |
| US-20020082384-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | US | claimed |
| EP-3953367-B1 | VERSATILE PEPTIDE AND PROTEIN MACROCYCLIZATION AND MULTIMERIZATION WITH DIELS-ALDER CYCLOADDITIONS | UNIV CHICAGO (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4600411-A2 | VERSATILE PEPTIDE AND PROTEIN MACROCYCLIZATION AND MULTIMERIZATION WITH DIELS-ALDER CYCLOADDITIONS | The University of Chicago (US) | 2025-08-13 | — | — | EP | disclosed |
| US-20250122240-A1 | Versatile Peptide and Protein Macrocyclization and Multimerization with Diels-Alder Cycloadditions | THE UNIVERSITY OF CHICAGO (US) | 2025-04-17 | — | — | US | disclosed |
| US-12209143-B2 | Versatile peptide and protein macrocyclization and multimerization with diels-alder cycloadditions | THE UNIVERSITY OF CHICAGO (US) | 2025-01-28 | — | — | US | disclosed |
| WO-2025006976-A2 | MRNA DISPLAY LIBRARIES AND METHODS OF USE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-01-02 | — | — | WO | disclosed |
| CN-117003815-A | SG2C bromobenzyl ether derivative, preparation method and application | 江苏省原子医学研究所 | 2023-11-07 | — | — | CN | disclosed |
| EP-1679318-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2006-07-12 | — | — | EP | disclosed |
| EP-1337549-B1 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE SA (CH) | 2006-04-05 | — | — | EP | disclosed |
| US-20050239162-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2005-10-27 | — | — | US | disclosed |
| EP-1337549-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002050099-A2 | PROCESS FOR FOLDING CHEMICALLY SYNTHESIZED POLYPEPTIDES | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | WO | disclosed |
| US-20020082384-A1 | Process for folding chemically synthesized polypeptides | RMF DICTAGENE S.A. (CH) | 2002-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122240-A1 | Versatile Peptide and Protein Macrocyclization and Multimerization with Diels-Alder Cycloadditions | SPPL2B, MAX, DNPEP | PTGS1 4447/4885SLC7A11 2830/4885ENPEP 33/4885 |
| US-12209143-B2 | Versatile peptide and protein macrocyclization and multimerization with diels-alder cycloadditions | SPPL2B, MAX, DNPEP | PTGS1 4447/4885SLC7A11 2830/4885ENPEP 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.